Morning Briefing
Summaries of health policy coverage from major news organizations
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
MedPage Today: Midlife Vitamin D Levels Tied To Alzheimer's-Related Brain Changes
Higher serum levels of 25-hydroxyvitamin D in midlife were tied to lower levels of subsequent tau pathology, an Alzheimer's disease biomarker, in a prospective cohort study. (George, 4/1)
MedPage Today: Base-Editing Gene Therapy Shows Promise In Sickle Cell Disease
Treatment with the investigational base-editing gene therapy ristoglogene autogetemcel (risto-cel) showed promise in patients with sickle cell disease, according to an interim analysis of the phase I/II BEACON study. (Bassett, 4/1)
MedPage Today: New TYK2 Inhibitors For Psoriasis Achieve High Clearance Rates In Randomized Trials
Two drug candidates to expand oral therapy options for psoriasis had similar and consistent performances in separate phase III clinical trials reported here. (Bankhead, 4/1)
MedPage Today: KT Tape May Not Be All That Helpful For Joint, Muscle Pain
Kinesio taping -- also known as KT tape -- may dampen joint and muscle pain in the short term, but the evidence is highly uncertain, an overview of systematic reviews showed. (Henderson, 3/31)
The New York Times: Can Science Predict When A Study Won’t Hold Up?
Scientists publish more than 10 million studies and other publications a year. Some of those findings will add to humanity’s storehouse of knowledge. But some will be wrong. To assess a study, scientists can replicate it to see if they get the same result. But seven years ago, a team of hundreds of scientists set out to find a faster way to judge new scientific literature. They built artificial intelligence systems to predict whether studies would hold up to scrutiny. (Zimmer, 4/1)
